NCT00446043View on ClinicalTrials.gov

Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

February 17, 2004

Primary Completion Date

May 23, 2005

Study Completion Date

May 23, 2005

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene/Benzoyl Peroxide

Adapalene 0.1 percent (%) \[weight by weight (W/W)\] and benzoyl peroxide 2.5 % (W/W) gel topically daily in the evening.

Trial Locations (1)

97210

Phoebe Rich, MD, Portland

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00446043 - Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects | Biotech Hunter | Biotech Hunter